Equities

Axim Biotechnologies Inc

AXIM:QBB

Axim Biotechnologies Inc

Actions
  • Price (USD)0.015
  • Today's Change0.000 / 1.35%
  • Shares traded136.39k
  • 1 Year change-45.89%
  • Beta1.1992
Data delayed at least 15 minutes, as of May 01 2024 19:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Axim Biotechnologies, Inc. is an international healthcare diagnostic solutions development company. The Company is focused on improving the landscape for the diagnosis of ophthalmological conditions such as dry eye disease (DED) through rapid diagnostic tests. It has developed and commercialized two highly specialized point-of-care (POC) diagnostic tests, Ocular Immunoglobulin E (IgE) test and Lactoferrin test, which are designed specifically to assist eye-care physicians in detecting and quantifying biomarkers associated with aqueous deficient DED and non-specific allergic conjunctivitis. In addition, it is also engaged in the development of a quantitative tear MMP-9 test to measure the intensity of inflammation affecting dry eye patients. It has also developed proprietary assays for the detection of QSOX1-L in patients undergoing cancer treatment. Its products also include SARS-CoV-2 neutralizing antibody tests and a fentanyl neutralizing antibody test.

  • Revenue in USD (TTM)39.77k
  • Net income in USD-8.06m
  • Incorporated2010
  • Employees6.00
  • Location
    Axim Biotechnologies Inc6191 Cornerstone Court, E, Suite 114SAN DIEGO 92121United StatesUSA
  • Phone+1 (212) 751-0001
  • Fax+1 (775) 786-6755
  • Websitehttps://aximbiotech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zyversa Therapeutics Inc0.00-106.25m3.98m7.00--0.1917-----1,922.89-1,922.890.0027.330.00----0.00-139.81---160.83--------------0.00-------340.15------
Aditxt Inc645.19k-32.70m4.01m47.00--0.198--6.22-153.12-153.122.1412.170.02330.89271.3813,727.45-117.12-192.78-251.19-321.59-17.30---5,020.30-7,208.650.2382-4.090.5020---30.90---18.11------
Evoke Pharma Inc5.18m-7.79m4.07m4.00------0.7855-2.33-2.331.55-0.77160.54760.52357.981,295,158.00-82.37-100.48-109.52-151.1096.10---150.41-480.522.09-20.562.07--106.51--5.25------
Reliv International Inc35.13m-175.48k4.07m208.00--0.588110.190.116-0.1005-0.100520.126.552.098.02228.49---1.05-4.65-1.47-6.0640.9041.98-0.4996-2.331.07--0.1064---2.94-9.3776.65---35.85--
Axim Biotechnologies Inc39.77k-8.06m4.18m6.00------105.01-0.0366-0.03660.0001-0.03110.0095----6,628.33-193.43-154.34---390.73-----20,265.75-36,362.71---0.62----345.05-27.38-29.10------
Artelo Biosciences Inc0.00-9.29m4.20m6.00--0.3528-----3.12-3.120.003.690.00----0.00-55.51---59.59--------------0.00------7.87------
SYBLEU Inc11.70k-307.88k4.30m--------367.87-0.0293-0.02930.0011-0.03670.0641-------168.63-----------2,631.45-----8.484.96--0.00--26.51------
Bio Path Holdings Inc0.00-16.08m4.32m10.00--3.87-----35.76-35.760.000.71360.00----0.00-167.56-70.80-206.12-76.87------------0.00-------15.94------
China Pharma Holdings Inc7.01m-3.08m4.34m231.00--0.4171--0.6184-1.06-1.062.070.70160.40942.1815.1430,351.95-17.98-29.66-41.91-55.25-4.016.47-43.91-73.090.332-8.420.3121---13.48-10.6822.50---25.78--
Mosaic Immunoengineering Inc0.00-1.01m4.35m3.00---------0.1397-0.13970.00-0.81070.00----0.00-457.45-----------------35.84--------57.65------
Neximmune Inc0.00-32.34m4.36m6.00--0.9661-----30.86-30.860.003.290.00----0.00-125.24-115.07-178.52-165.07------------0.00------48.25---44.65--
GT Biopharma Inc0.00-7.60m4.38m2.00--0.5855-----5.57-5.570.005.410.00----0.00-49.26-205.36-78.83--------------0.00------63.62------
Exicure Inc23.79m3.07m4.41m7.000.3990.45451.070.18541.281.283.861.120.8729----1,830,000.0011.25-41.7518.34-55.57----12.88-302.07----0.00--6,068.1224.2995.97---59.57--
Marijuana Company Of America Inc1.50m-13.01m4.42m7.00------2.95-0.0071-0.00710.0003-0.00360.31375.617.64214,085.70-272.25-837.07----28.3739.75-867.96-3,809.920.031-0.6498----267.09159.6516.09------
Tharimmune Inc0.00-9.32m4.42m2.00--0.4821-----13.09-13.090.000.77780.00----0.00-105.69---127.01--------------0.00-------9.98------
Marizyme Inc590.91k-79.15m4.43m13.00------7.50-1.83-1.830.0139-0.47040.01170.957512.1345,454.62-157.28-29.47-314.26-30.4271.6367.78-13,393.85-8,518.470.025-0.5887----11.0418.20-247.03------
Data as of May 01 2024. Currency figures normalised to Axim Biotechnologies Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.